Dual drug targeting to kill colon cancers
Abstract Introduction Colorectal cancer (CRC) is driven by a small set of oncogenic and tumour suppressor mutations. However, different combinations of mutations often lead to poor tumour responses to individual anticancer drugs. We have investigated the antiproliferative and in vitro cytotoxic acti...
| Published in: | Cancer Medicine |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-07-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.4641 |